Micro- and nanoplastics in the human genitourinary system: oncological impact - a systematic review
Abstract
Objectives: To systematically assess the prevalence, distribution, and quantitative burden of micro- and nanoplastics (MNPs) in human tissues of the urinary tract and male reproductive organs, with particular attention to their potential oncological implications.
Methods: This systematic review was conducted in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. A systematic search of PubMed, Embase, and Scopus was performed to identify human observational studies reporting detection and/or quantification of MNPs in the urinary tract and male reproductive organs. Risk of bias was assessed in the included studies.
Results: A total of 14 cross-sectional human studies were included. MNPs were detected across all investigated tissues, including the kidney, prostate, testis, penis, ureter, and, incidentally, the urinary bladder. All studies comparing malignant and adjacent non-malignant tissues (kidney, prostate, and penis) consistently reported significantly higher microplastic concentrations, particle counts or greater polymer diversity in tumour tissue. Considerable heterogeneity was observed across studies with respect to analytical techniques, digestion protocols, and reporting metrics.
Conclusions: Micro- and nanoplastics are widely present in tissues of the urinary tract and male reproductive system and show consistent enrichment in urological malignancies compared with adjacent non-malignant tissue, suggesting potential…
How strong is the evidence?
Evidence Hub reads this as a systematic review, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.